Sign In
Buy INMB
$1.32
-0.1000 (-7.04%)
At Close: Jun 03, 2026
Do Hedge Funds Love Inmune Bio Inc. (INMB)?
10:59am, Friday, 27'th Nov 2020
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilitie
Top 10 Stocks Billionaire George Soros Just Bought
02:34am, Sunday, 15'th Nov 2020
In this article we present the list of Top 10 Stocks Billionaire George Soros Just Bought. Click to skip ahead and see the Top 5 Stocks Billionaire George Soros Just Bought .
INmune Bio, Inc. Announces First Patient Dosed in Phase 2 Trial of Quellor™ for Pulmonary Complications in COVID-19 Patients
07:00am, Monday, 09'th Nov 2020
LA JOLLA, Calif, Nov. 09, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient's
INmune Bio, Inc. (INMB) CEO RJ Tesi on Q3 2020 Results - Earnings Call Transcript
04:24am, Sunday, 08'th Nov 2020
INmune Bio, Inc. (INMB) CEO RJ Tesi on Q3 2020 Results - Earnings Call Transcript
INmune Bio, Inc. to Report Third Quarter 2020 Financial Results and Provide a Corporate Update on Thursday, November 5
08:30am, Thursday, 29'th Oct 2020
Management to host conference call at 4:30 pm ET on that day
IPHA LOSS NOTICE: Rosen Law Firm Announces Investigation of Securities Claims Against Innate Pharma S.A – IPHA
12:00am, Wednesday, 21'st Oct 2020
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Innate Pharm
INmune Bio (INMB) Investor Presentation - Slideshow
10:08am, Thursday, 03'rd Sep 2020
The following slide deck was published by INmune Bio, Inc. in conjunction with this event..
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
12:00am, Wednesday, 19'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 18)
Avenue Therapeutics Inc (NASDAQ: ATXI)
Checkmate Pharmaceuticals Inc (NASDAQ: CMPI)
DarioHealth Corp (NASDAQ:...
European Patent Granted Covering INmune Bio’s XPro1595
01:00pm, Thursday, 13'th Aug 2020
LA JOLLA, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient�
INmune Bio, Inc. Announces Second Quarter 2020 Results and Provides Business Update
08:01pm, Wednesday, 05'th Aug 2020
The company will host an earnings call: Today, August 5 at 4:30 PM ETLA JOLLA, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), an immunology company d
INmune Bio, Inc to Present at the BTIG Virtual Biotechnology Conference 2020
11:00am, Monday, 03'rd Aug 2020
LA JOLLA, Calif, Aug. 03, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage immunology company focused on developing treatments that harn
INmune Bio, Inc. Schedules Conference Call to Report 2020 Second Quarter Financial Results
11:00am, Friday, 31'st Jul 2020
LA JOLLA, Calif, July 31, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage immunology company focused on developing treatments that harn
INmune Bio, Inc. Featured on Fox News (VIDEO): STNF and Cytokine Storm
11:00am, Monday, 27'th Jul 2020
LA JOLLA, Calif, July 27, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient�
Southern California Bancorp Announces Results for the Second Quarter 2020
12:00am, Monday, 27'th Jul 2020
Southern California Bancorp (the “Company”) (OTC Pink: BCAL), the holding company for Bank of Southern California, N.A. (the “Bank”) today reported re
LA JOLLA, Calif., July 20, 2020 -- In a release issued under the same headline on Monday, July 20th by INmune Bio, Inc. (NASDAQ: INMB) was incorrectly reported with below.
